title: [Practice of antidiabetic therapy in Hungary].
abstract: Type 2 diabetes is one of the biggest public health problems of our age. In the present study the authors analyse the development of the therapy of type 2 diabetic patients. National antidiabetic consumption data and data of National Health Insurance Fund Administration (OEP) were used. From OEP database definite method were used to choose 1002 type 2 diabetic patients. The Hungarian therapeutic practice develops according to guidelines of multi centered studies, and the consumption of antidiabetics dynamically increases. Increasing the number of patients who get insulin therapy and among patients who get oral antidiabetics more of them get insulin resistance decreasing therapy. However the out-of-date drugs (non-micronized glibenclamide, buformin) are still in daily therapy. The authors revealed the ratio of diet and drug (monotherapy, combination therapy) therapy, the higher use of Sulfanylurea monotherapy than recommended and the use of unreasonable combinations.
authors.affiliation: Semmelweis Egyetem, Egyetemi Gyógyszertdár Gyógyszerügyi Szervezési Intézet, Budapest.
authors.forename: Balázs Zoltán
authors.initials: BZ
authors.lastname: Hankó
authors.forename: Csilla Andrea
authors.initials: CA
authors.lastname: Reszegi
authors.forename: Péter
authors.initials: P
authors.lastname: Kumli
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Vincze
mesh_terms: D000284:Administration, Oral; D016208:Databases, Factual; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D006814:Hungary; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin